<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">30652745</article-id><article-id pub-id-type="pmc">6326435</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2018-0001</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Does Moderate Coronary Stenosis Affect the Fate of the Left Internal
Thoracic Artery Graft?</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Caliskan</surname><given-names>Aytac</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Unal</surname><given-names>Ertekin Utku</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Kubat</surname><given-names>Emre</given-names></name><xref ref-type="aff" rid="aff3">3</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Aytekin</surname><given-names>Bahadir</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Turkcan</surname><given-names>Basak Soran</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Kiris</surname><given-names>Erman Sureyya</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Tola</surname><given-names>Muharrem</given-names></name><xref ref-type="aff" rid="aff4">4</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Iscan</surname><given-names>Hakki Zafer</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>MD</role></contrib></contrib-group><aff id="aff1">
<label>1</label> Cigli District Training Hospital, Cardiovascular Surgery, Izmir,
Turkey. </aff><aff id="aff2">
<label>2</label> Turkey Yuksek Ihtisas Training and Research Hospital,
Cardiovascular Surgery Ankara, Turkey. </aff><aff id="aff3">
<label>3</label> Karabuk Training and Research Hospital, Cardiovascular Surgery,
Karabuk, Turkey. </aff><aff id="aff4">
<label>4</label> Turkey Yuksek Ihtisas Training and Research Hospital, Radiology,
Ankara,Turkey. </aff><author-notes><corresp id="c1">Correspondence Address: Aytac Caliskan, Cigli Training Hospital,
Cardiovascular Surgery, Yenimahalle Mahallesi, 8780/1 Sokak, no18, Cigli, Izmir,
TR 35620. E-mail: <email>aytac.caliskan@gmail.com</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Nov-Dec</season><year>2018</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Nov-Dec</season><year>2018</year></pub-date><volume>33</volume><issue>6</issue><fpage>567</fpage><lpage>572</lpage><history><date date-type="received"><day>02</day><month>1</month><year>2018</year></date><date date-type="accepted"><day>28</day><month>6</month><year>2018</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Introduction</title><p>In this study we try to observe the fate of the left internal thoracic artery
grafts that were bypassed to left anterior descending artery with moderate
stenosis identified with fractional flow reserve (FFR) technique. Doppler
ultrasonography was chosen as a noninvasive screening method.</p></sec><sec><title>Methods</title><p>A total of 30 patients who underwent coronary artery bypass grafting
depending on results of the fractional flow reserve between January 2007 and
January 2012, were subjected to transthoracic color Doppler ultrasonographic
evaluation irrespective of the presence of symptoms, and the presence of a
systolic-diastolic flow pattern was investigated using the supraclavicular
approach.</p></sec><sec><title>Results</title><p>The left internal thoracic artery graft was found to be functional in 63.3%
of patients within a mean period of 35.1&#x000b1;19.7 months between coronary
bypass and color Doppler ultrasonography. This period was found to be
29.4&#x000b1;19.6 months in the functional graft group, and 44.7&#x000b1;16.6
months in the dysfunctional graft group (<italic>P</italic>=0.046).
Preoperative complaints of angina were reported to fall from 88.9% to 16.7%
in the functional graft group, when compared to the postoperative period
(<italic>P</italic>&#x0003c;0.001), but fell from 90.9% to 36.4% in the
dysfunctional graft group (<italic>P</italic>=0.034).</p></sec><sec><title>Conclusion</title><p>Functional left internal thoracic artery graft rates of the study population
were found to be lower than the studies reported in the literature.</p></sec></abstract><kwd-group><kwd>Coronary Angiography</kwd><kwd>Coronary Artery Bypass</kwd><kwd>Ultrasonography</kwd><kwd>Internal Mammary-Coronary Artery Anastomosis</kwd><kwd>Coronary Stenosis</kwd></kwd-group></article-meta></front><body><table-wrap id="t4" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="25%" span="1"/><col width="75%" span="1"/></colgroup><thead><tr style="background-color:#eaeaea"><th align="left" colspan="2" rowspan="1">Abbreviations, acronyms &#x00026; symbols</th></tr></thead><tbody><tr style="background-color:#eaeaea"><td align="left" rowspan="1" colspan="1"><bold>CABG</bold></td><td align="left" rowspan="1" colspan="1"><bold>= Coronary artery bypass grafting</bold></td></tr><tr style="background-color:#eaeaea"><td align="left" rowspan="1" colspan="1"><bold>CAG</bold></td><td align="left" rowspan="1" colspan="1"><bold>= Coronary angiography</bold></td></tr><tr style="background-color:#eaeaea"><td align="left" rowspan="1" colspan="1"><bold>CDUS</bold></td><td align="left" rowspan="1" colspan="1"><bold>= Color Doppler ultrasonography</bold></td></tr><tr style="background-color:#eaeaea"><td align="left" rowspan="1" colspan="1"><bold>FFR</bold></td><td align="left" rowspan="1" colspan="1"><bold>= Fractional flow reserve</bold></td></tr><tr style="background-color:#eaeaea"><td align="left" rowspan="1" colspan="1"><bold>ITAG</bold></td><td align="left" rowspan="1" colspan="1"><bold>= Internal thoracic artery grafts</bold></td></tr><tr style="background-color:#eaeaea"><td align="left" rowspan="1" colspan="1"><bold>LAD</bold></td><td align="left" rowspan="1" colspan="1"><bold>= Left anterior descending artery</bold></td></tr><tr style="background-color:#eaeaea"><td align="left" rowspan="1" colspan="1"><bold>NYHA</bold></td><td align="left" rowspan="1" colspan="1"><bold>= New York Heart Association</bold></td></tr><tr style="background-color:#eaeaea"><td align="left" rowspan="1" colspan="1"><bold>PCI</bold></td><td align="left" rowspan="1" colspan="1"><bold>= Percutaneous coronary interventions</bold></td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Results of the interventions to severe coronary artery stenoses are mostly
predictable. However, controversy still exists concerning moderate stenoses. Rapid
increase in plaque sizes of borderline lesions have been reported, and long periods
of nonintervention with these lesions can lead to undesirable cardiac
events<sup>[<xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref>]</sup>. Coronary artery bypass grafting (CABG) to
moderately stenotic coronary vessels that were diagnosed by qualitative coronary
angiography (CAG), is associated with lower long-term
mortality<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>. But the success of surgical intervention in
moderate stenoses is suggested to be associated with the functional importance of
the lesion. Fractional flow reserve (FFR) is the suggested technique to decide the
functional importance of a moderate coronary stenosis<sup>[<xref rid="r4" ref-type="bibr">4</xref>]</sup>. FFR has a very critical
role in a surgeon's decision because a graft that was bypassed to a coronary artery
with a functionally insignificant stenosis may be dysfunctional as a result of the
competitive flow<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup>. In this study we try to observe the fate of the
left internal thoracic artery grafts (ITAG) that were bypassed to left anterior
descending artery (LAD) with moderate stenoses that were identified with FFR
technique. The patients were included in the study regardless of their symptom
status so we chose color Doppler ultrasonography (CDUS) as a noninvasive screening
method. The studies, which have demonstrated that CDUS could detect ITAG patency at
a rate of over 90%, had encouraged us to choose CDUS as a screening
method<sup>[<xref rid="r6" ref-type="bibr">6</xref>,<xref rid="r7" ref-type="bibr">7</xref>]</sup>.</p></sec><sec sec-type="methods"><title>METHODS</title><sec><title>Study Patients</title><p>A cross-sectional examination, from the data of 494 patients who were subjected
to FFR for LAD between January 2007 and January 2012, was conducted. In our
institution, experienced interventional cardiologists and surgeons decide the
severity of the lesion mostly by visual assessment, but FFR is performed in case
of suspected moderate stenosis. The decision to perform CABG has been made for
patients with a FFR value &#x02264;0.80. Patients needing associated valve
surgery and emergent CABG (defined as within 24 hours of the index procedure)
were excluded. The 128 patients who underwent CABG at our hospital and who could
be contacted by phone or by mail were invited for outpatient follow-ups; 30 of
these invited patients responded to the calls and came for follow-up controls.
Data concerning the variables were obtained from patients' medical records in
the automation system, and from patient files. Patients were also examined
according to the New York Heart Association (NYHA) functional capacity and the
presence of angina, on arrival at the hospital for follow-up. Evaluation of
angina was made according to standard guidelines recommendations as 'definite
angina', 'probable angina', 'probably not angina' and 'definitely not angina';
and patients in the 'definite angina' and 'probable angina' group were
considered as having angina<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>. All the patients were subjected to
transthoracic echocardiography. Transthoracic CDUS was also performed in all the
patients for the assessment of ITAG irrespective of the presence of symptoms.
CAG was recommended to all patients who reported postoperative angina complaints
during their outpatient follow-up visits.</p></sec><sec><title>Surgical Technique</title><p>While preparing the ITAG after median sternotomy in all patients, the great
saphenous vein was used as a graft in all patients who were scheduled for bypass
in more than one vessel. The ITAG was prepared from the origin of the subclavian
artery to the superior epigastric and musculophrenic branches in the sixth
intercostal space, using low-current electrocautery and hemoclips in the side
branches, releasing it together with the pedicle and wrapping it with papaverine
gas tampon. ITAG was harvested in all cases by senior residents.</p><p>Standard cannulation was made from the ascending aorta and the right atrium
(two-stage venous cannula). The targeted heparinization was accomplished at
300-400 IU/kg and a target activated clotting time is 480 seconds. Surgery was
performed under mild hypothermia (34-35&#x000ba;C). We did not observe any off-pump
operation in study population.</p><p>The ITAG of all patients in the study population was anastomosed to the LAD. No
medication was administered to the patients after surgery to prevent bleeding.
All patients were transferred to the postoperative intensive care unit and
placed on a mechanical ventilator for a few hours for follow-up.</p></sec><sec><title>CDUS Technique</title><p>All CDUS conducted for the visualization of the ITAG was performed using the
Logiq 7 (Medical Systems, Milwaukee, WI, USA) Doppler ultrasonographic device
and the 3-7 MHz multi-frequency linear probe. Examination of the ITAG was made
using the CDUS by the supraclavicular approach, to visualize the subclavian
artery towards the origin of the vertebral artery in the vertical plane. The
presence of a cystolo-diastolic flow pattern was then investigated by
visualizing the origin of the internal thoracic artery in the form of a tubular
structure with the probe rotated caudally 90 degrees clockwise. Patients, whose
cystolo-diastolic flow pattern in ITAG could not be examined, were considered to
have dysfunctional grafts.</p></sec><sec><title>Statistical Analysis</title><p>Continuous numerical variables are expressed as "mean &#x000b1; standard deviation
(SD)" of descriptive statistical analysis. On the other hand, the cut-off and
categorized data are expressed as "number" and "percentage (%)". The "Chi-square
test" and the "Fisher test" were used to compare categorized variables.
Independent variables which were inconsistent with normal distribution were
analyzed using the nonparametric "Mann-Whitney U test". The difference between
inter-group preoperative and postoperative variables was obtained using the
"Wilcoxon test". On the other hand, the time-dependent functional ITAG rate was
evaluated using "Kaplan-Meier analysis". The "<italic>P</italic> value" was
determined as "&#x003b1;=0.05" in all data analyses for the assessment of
statistical significance level. Data were analyzed using the "IBM SPSS
Statistics Version 15.0" packet program.</p></sec></sec><sec sec-type="results"><title>RESULTS</title><p>Basic demographic and clinical characteristics of the 30 patients who form the study
population are shown in <xref rid="t1" ref-type="table">Table 1</xref>.</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Basic demographic and intraoperative characteristics of the patients.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="28%" span="1"/><col width="18%" span="1"/><col width="18%" span="1"/><col width="18%" span="1"/><col width="18%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Characteristics of the patients</th><th align="center" rowspan="1" colspan="1">n</th><th align="center" rowspan="1" colspan="1">%</th><th align="center" rowspan="1" colspan="1">Mean &#x000b1; SD</th></tr></thead><tbody><tr><td align="left" rowspan="2" colspan="1">Gender&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;</td><td align="left" rowspan="1" colspan="1">Female</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">16.7</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Male</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">83.3</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" colspan="2" rowspan="1">Age (years)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">63.6&#x000b1;9.6</td></tr><tr><td align="left" colspan="2" rowspan="1">Diabetes mellitus</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">13.3</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" colspan="2" rowspan="1">Hypertension</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">70.0</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" colspan="2" rowspan="1">Peripheral artery disease</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">6.7</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" colspan="2" rowspan="1">Hyperlipidemia</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">46.7</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" colspan="2" rowspan="1">Smoking</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">33.3</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" colspan="2" rowspan="1">Carotid stenosis</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">3.3</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" colspan="2" rowspan="1">CKD</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">10.0</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" colspan="2" rowspan="1">SVE</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" colspan="2" rowspan="1">COPD</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">3.3</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" colspan="2" rowspan="1">FFR value</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">0.69&#x000b1;0.06</td></tr><tr><td align="left" colspan="2" rowspan="1">EF (%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">54.4&#x000b1;7.9</td></tr><tr><td align="left" colspan="2" rowspan="1">CPB</td><td align="center" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">100.0</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" colspan="2" rowspan="1">The number of distal coronary bypasses</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">2.10&#x000b1;0.88</td></tr><tr><td align="left" colspan="2" rowspan="1">Patients who underwent single vessel
coronary artery bypass</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">33.3</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" colspan="2" rowspan="1">Patients who underwent two or more vessel
coronary artery bypass</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">66.7</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr></tbody></table><table-wrap-foot><fn id="TFN01"><p>CKD=chronic kidney disease; COPD=chronic obstructive pulmonary disease;
CPB=cardiopulmonary bypass; EF=ejection fraction; FFR=fractional flow
reserve; SD=standard deviation; SVE=cerebrovascular event</p></fn></table-wrap-foot></table-wrap><p>Preoperative and postoperative distribution and comparison of symptoms and functional
capacities of patients are seen in <xref rid="t2" ref-type="table">Table 2</xref>.
No statistically significant difference was found between the preoperative and
postoperative functional capacities of the patients (<italic>P</italic>=0.059).
However, patients were reported to have improved from their angina during the
postoperative follow-ups (<italic>P</italic>&#x0003c;0.001). Angina complaints have been
reduced significantly in patients with single-vessel bypass, as well as in those who
underwent coronary artery bypass grafting in two or more vessels
(<italic>P</italic>=0.008 and <italic>P</italic>=0.001, respectively).</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Preoperative and postoperative distribution and comparison of patient
symptoms and functional capacity values.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="24%" span="1"/><col width="19%" span="1"/><col width="19%" span="1"/><col width="19%" span="1"/><col width="19%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Characteristics</th><th align="center" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">n</th><th align="center" rowspan="1" colspan="1">%</th><th align="center" rowspan="1" colspan="1"><italic>P</italic> value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Preoperative FC&#x000a0;&#x000a0;&#x000a0;</td><td align="center" rowspan="1" colspan="1">NYHA 1</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">60.0</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">NYHA 2</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">23.3</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">NYHA 3</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">16.7</td><td align="center" rowspan="1" colspan="1">0.059</td></tr><tr><td align="left" rowspan="1" colspan="1">Postoperative FC&#x000a0;</td><td align="center" rowspan="1" colspan="1">NYHA 1</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">70.0</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">NYHA 2</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">30.0</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Preoperative angina</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1">89.7</td><td align="center" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Postoperative angina</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">24.1</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr></tbody></table><table-wrap-foot><fn id="TFN02"><p>FC=functional capacity; NYHA=New York Heart Association</p></fn></table-wrap-foot></table-wrap><p>Apart from the CABG, three (10%) patients were subjected to additional intervention
with one patient undergoing septal myectomy, one patient carotid endarterectomy,
while one patient also underwent repair of femoral artery pseudoaneurysm.</p><p>The median FFR value was found to be 0.70 (range: 0.56-0.80). Only two patients were
found to be in the 0.75-0.80 range.</p><p>The mean period of postoperative stay in the intensive care unit was found to be
1.8&#x000b1;3.1 days for all patients, whereas the postoperative period for
hospitalization was reported as 6.3&#x000b1;4.1 days. The mean period between CABG
and CDUS was found to be 35.1&#x000b1;19.7 months.</p><p>Results from CDUS conducted during outpatient follow-up visits demonstrated that the
ITAG was functional in 63.3% of the patients (19 patients). Patients were then
divided into two groups (functional and dysfunctional) according to assessment of
ITAG, and the statistically significant difference between the groups evaluated
(<xref rid="t3" ref-type="table">Table 3</xref>). A significant difference was
reported between the two groups with regards only to the duration between CABG and
CDUS. This duration was found to be 29.4&#x000b1;19.6 months in the group with
functional ITAG, and 44.7&#x000b1;16.6 months in the dysfunctional group
(<italic>P</italic>=0.046).</p><table-wrap id="t3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Comparison of demographic and clinical characteristics of patients with
functional and dysfunctional ITAG on color CDUS.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="20%" span="1"/><col width="18%" span="1"/><col width="12%" span="1"/><col width="12%" span="1"/><col width="12%" span="1"/><col width="12%" span="1"/><col width="12%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">&#x000a0;</th><th align="center" colspan="2" rowspan="1">Functional</th><th align="center" colspan="3" rowspan="1">Dysfunctional</th></tr><tr><th align="left" colspan="2" rowspan="1">Characteristics</th><th align="center" rowspan="1" colspan="1">n (%)</th><th align="center" rowspan="1" colspan="1">Mean &#x000b1; SS</th><th align="center" rowspan="1" colspan="1">n (%)</th><th align="center" rowspan="1" colspan="1">Mean&#x000b1; SD</th><th align="center" rowspan="1" colspan="1"><italic>P</italic> value</th></tr></thead><tbody><tr><td align="left" rowspan="2" colspan="1">Gender&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;</td><td align="left" rowspan="1" colspan="1">Female</td><td align="center" rowspan="1" colspan="1">2 (10.5)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">3 (27.3)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">0.327</td></tr><tr><td align="left" rowspan="1" colspan="1">Male</td><td align="center" rowspan="1" colspan="1">17 (89.5)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">8 (72.7)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" colspan="2" rowspan="1">Age (years)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">63.4&#x000b1;10.4</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">64&#x000b1;8.6</td><td align="center" rowspan="1" colspan="1">0.800</td></tr><tr><td align="left" colspan="2" rowspan="1">Diabetes mellitus</td><td align="center" rowspan="1" colspan="1">4 (21.1)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">0.268</td></tr><tr><td align="left" colspan="2" rowspan="1">Hypertension</td><td align="center" rowspan="1" colspan="1">13 (68.4)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">8 (72.7)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">0.804</td></tr><tr><td align="left" colspan="2" rowspan="1">Peripheral artery disease</td><td align="center" rowspan="1" colspan="1">1 (5.3)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">1 (9.1)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" colspan="2" rowspan="1">Hyperlipidemia</td><td align="center" rowspan="1" colspan="1">8 (42.1)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">6 (54.5)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">0.510</td></tr><tr><td align="left" colspan="2" rowspan="1">Smoking</td><td align="center" rowspan="1" colspan="1">7 (36.8)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">3 (27.3)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">0.592</td></tr><tr><td align="left" colspan="2" rowspan="1">Carotid stenosis</td><td align="center" rowspan="1" colspan="1">1 (5.3)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" colspan="2" rowspan="1">CKD</td><td align="center" rowspan="1" colspan="1">2 (10.5)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">1 (9.1)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" colspan="2" rowspan="1">COPD</td><td align="center" rowspan="1" colspan="1">1 (5.3)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" colspan="2" rowspan="1">FFR value</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">0.68&#x000b1;0.06</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">0.72&#x000b1;0.04</td><td align="center" rowspan="1" colspan="1">0.310</td></tr><tr><td align="left" colspan="2" rowspan="1">EF (%)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">53.8&#x000b1;9.3</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">55.4&#x000b1;4.7</td><td align="center" rowspan="1" colspan="1">0.767</td></tr><tr><td align="left" colspan="2" rowspan="1">Additional procedure</td><td align="center" rowspan="1" colspan="1">3 (15.3)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">0.279</td></tr><tr><td align="left" colspan="2" rowspan="1">Coronary bypass number</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">2.05&#x000b1;0.97</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">2.18&#x000b1;0.75</td><td align="center" rowspan="1" colspan="1">0.800</td></tr><tr><td align="left" colspan="2" rowspan="1">Preoperative angina</td><td align="center" rowspan="1" colspan="1">16 (88.9)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">10 (90.9)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" colspan="2" rowspan="1">Postoperative angina</td><td align="center" rowspan="1" colspan="1">3 (16.7)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">4 (36.4)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">0.375</td></tr><tr><td align="left" colspan="2" rowspan="1">Postoperative CKD</td><td align="center" rowspan="1" colspan="1">1 (5.3)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" colspan="2" rowspan="1">Postoperative MI</td><td align="center" rowspan="1" colspan="1">1 (5.3)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" colspan="2" rowspan="1">Postoperative low cardiac output</td><td align="center" rowspan="1" colspan="1">1 (5.3)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" colspan="2" rowspan="1">Postoperative others</td><td align="center" rowspan="1" colspan="1">2 (10.5)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">0.520</td></tr><tr><td align="left" colspan="2" rowspan="1">Postoperative stay in ICU (days)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">2.1&#x000b1;3.8</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">1.4&#x000b1;0.9</td><td align="center" rowspan="1" colspan="1">0.902</td></tr><tr><td align="left" colspan="2" rowspan="1">Postoperative hospitalization (days)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">6.5&#x000b1;5.1</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">6.0&#x000b1;1.2</td><td align="center" rowspan="1" colspan="1">0.359</td></tr><tr><td align="left" colspan="2" rowspan="1">Duration between CABG and CDUS
(months)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">29.4&#x000b1;19.6</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">44.7&#x000b1;16.6</td><td align="center" rowspan="1" colspan="1">0.046</td></tr></tbody></table><table-wrap-foot><fn id="TFN03"><p>CABG=coronary artery bypass grafting; CDUS=color Doppler ultrasonography;
CKD=chronic kidney disease; COPD=chronic obstructive pulmonary disease,
EF=ejection fraction; FC=functional capacity; FFR=fractional flow
reserve; ICU=intensive care unit, ITAG: internal thoracic artery graft;
MI=myocardial infarction; NYHA=New York Heart Association; SD=standard
deviation</p></fn></table-wrap-foot></table-wrap><p>There was no significant difference between the two groups with regards to the
preoperative and postoperative functional capacities (ITAG functional group
<italic>P</italic>=0.053; ITAG dysfunctional group
<italic>P=</italic>0.655).</p><p>Four of the patients who were found to be consistent with postoperative angina
accepted to undergo CAG. As a result, no statistically significant comparison was
performed.</p><p>Preoperative complaints of angina were reported to fall from 88.9% to 16.7% in the
functional ITAG group, when compared to the postoperative period
(<italic>P</italic>&#x0003c;0.001), whereas the complaints fell from 90.9% to 36.4% in
the dysfunctional ITAG group (<italic>P</italic>=0.034).</p><p>The functional ITAG rates of the patients according to CDUS are shown in <xref ref-type="fig" rid="f1">Figure 1</xref>. Accordingly, the two-year functional
graft rates were found to be 90.8%, whereas the three-year functional graft rates
were 76.6%.</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>5 year functional left ITAG rates with 95% CI and patients at risk
according to Kaplan Meier analysis.</p></caption><graphic xlink:href="rbccv-33-06-0567-g01"/></fig>
</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>About 63.3% of the ITAG of the patients who underwent CABG according to FFR values,
were found to be functional during a mean postoperative period of 35.1&#x000b1;19.7
months. Functional graft rates were found to be lower than the known patency rates
of the ITAG. In the dysfunctional ITAG group the period between CABG and CDUS was
found to be significantly longer than that observed in the functional ITAG
group.</p><p>Moderate coronary stenoses are currently being treated according to their functional
significance. Non-intervention for moderate stenoses, considered to be functionally
insignificant, has demonstrated to alter survival and the incidence of
angina<sup>[<xref rid="r9" ref-type="bibr">9</xref>]</sup>. Uneventful survival rate in cases with percutaneous
coronary interventions (PCI) performed according to FFR guidance has shown to be
higher than in procedures determined by CAG alone, and that FFR reduces the number
of vessels involved with, and the cost of PCI<sup>[<xref rid="r10" ref-type="bibr">10</xref>]</sup>. These findings are in line with
another study which shows that surgical revascularization of moderate lesions
according to their functional significance does not increase unwanted cardiac events
despite reducing the number of anastomoses<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup>. These results may be due to the fact
that the patency of grafts for coronary stenoses, considered as functionally severe,
is higher than that of those considered to be non-severe<sup>[<xref rid="r12" ref-type="bibr">12</xref>]</sup>.</p><p>ITAG is normally a conduit with a 10-year patency rate of 95%<sup>[<xref rid="r13" ref-type="bibr">13</xref>]</sup>. The fact that our
study population consisted of patients with moderate stenosis suggests that the low
functional ITAG rates (63.3%) may be due to native coronary blood flow. This flow in
native vessels is more pronounced in vessels with moderate stenosis than in those
with severe stenosis. Moderate target vessel stenoses have shown to be an
independent risk factor for arterial graft dysfunction and can particularly cause
grafts to become dysfunctional due to competitive flow, reducing the three-year
patency rates to less than 90%<sup>[<xref rid="r14" ref-type="bibr">14</xref>,<xref rid="r15" ref-type="bibr">15</xref>]</sup>. Due to the fact that arterial grafts reduce
disease progression and also ensure regression of existing
stenosis<sup>[<xref rid="r16" ref-type="bibr">16</xref>]</sup>, improvement in native coronary flow may be another
reason for dysfunctional ITAG in patients with moderate LAD stenosis as observed in
our study population. The flow in the native coronary artery may prevent graft
function when it is providing adequate perfusion to the myocardium distal to the
stenosis. This sufficient flow in the native vasculature may have rendered patients
to remain asymptomatic.</p><p>ITAG which could not be assessed with CDUS in our study were considered as being
dysfunctional. Literature studies show that the grafts of approximately 10% of
patients could not be evaluated with CDUS, and at least 60% of these grafts were
detected as being patent on CAG<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup>. Similarly, one of the reasons why the
functional ITAG rate was below the expected level can be attributed to such
limitations in the imaging procedure.</p><p>The small sample size of our study may be the most important limiting factor. The
period between CABG and CDUS are not homogeneous in the study population. Also study
results could be affected by the heterogeneity of surgical technique or even
surgeons, the diameter of coronary arteries as well as the severity of FFR values.
The FFR values in the grey zone, which is considered to be within the range of
0.75-0.80, were reported in only two patients; hence, a comparison could not be
performed according to lesion severity. There is another heterogeneity in the number
of diseased and bypassed vessels. Results obtained show that there was a significant
decrease in postoperative angina complaints in patients with single-vessel bypass,
as well as in those who were subjected to bypass grafting in two or more vessels
(<italic>P</italic>=0.008 and <italic>P</italic>=0.001). The ITAG was used only
at the LAD position in all of the patients and CDUS was used for visualizing only
the functional status of the ITAG. Occlusion of saphenous venous grafts of coronary
stenosis other than LAD may cause ischemia in some parts of the myocardium, leading
to observable symptoms, while saphenous grafts of vessels which are a source of
preoperative pain may remain patent, leading to asymptomatic features in the
patients. Finally, evaluation of graft function was performed with CDUS; however,
results could not be compared to CAG which is considered to be the golden
standard.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>This study may give us an idea that grafting of moderate coronary stenoses may
negatively affect graft patency rates. In order to assess the safety of determining
the hemodynamic importance of moderate lesions by the FFR technique, studies with
adequate and homogenous follow-up periods, involving a larger study population, and
whose CDUS results can be confirmed by CAG, are required so as to obtain more
definite results.</p><table-wrap id="t5" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="5%" span="1"/><col width="95%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1"><bold>Authors&#x02019; roles &#x00026;
responsibilities</bold></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">AC</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or the acquisition, analysis, or interpretation of data
for the work; final approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">EUU</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or the acquisition, analysis, or interpretation of data
for the work; final approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">EK</td><td align="left" rowspan="1" colspan="1">Drafting the work or revising it critically for
important intellectual content; final approval of the version to be
published</td></tr><tr><td align="left" rowspan="1" colspan="1">BA</td><td align="left" rowspan="1" colspan="1">Final approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">BST</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or the acquisition, analysis, or interpretation of data
for the work; final approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">ESK</td><td align="left" rowspan="1" colspan="1">Substantial contributions to the conception or design
of the work; or the acquisition, analysis, or interpretation of data
for the work; final approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">MT</td><td align="left" rowspan="1" colspan="1">Performed the echocardiographic evaluation; final
approval of the version to be published</td></tr><tr><td align="left" rowspan="1" colspan="1">HZI</td><td align="left" rowspan="1" colspan="1">Drafting the work or revising it critically for
important intellectual content; final approval of the version to be
published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="other"><p>This study was carried out at Cigli District Training Hospital, Cardiovascular
Surgery, Izmir, Turkey.</p></fn><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></fn-group><fn-group><fn fn-type="financial-disclosure"><p>No financial support.</p></fn><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moise</surname><given-names>A</given-names></name><name><surname>Th&#x000e9;roux</surname><given-names>P</given-names></name><name><surname>Taeymans</surname><given-names>Y</given-names></name><name><surname>Waters</surname><given-names>DD</given-names></name></person-group><article-title>Factors associated with progression of coronary artery disease in
patients with normal or minimally narrowed coronary arteries</article-title><source>Am J Cardiol</source><year>1985</year><volume>56</volume><issue>1</issue><fpage>30</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">4014037</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rzeczuch</surname><given-names>K</given-names></name><name><surname>Szajn</surname><given-names>G</given-names></name><name><surname>Jankowska</surname><given-names>E</given-names></name><name><surname>Kaczmarek</surname><given-names>A</given-names></name><name><surname>Derkacz</surname><given-names>A</given-names></name><name><surname>Porada</surname><given-names>A</given-names></name><etal/></person-group><article-title>Borderline coronary lesions may lead to serious coronary events:
long-term outcome in 65 conservatively treated patients</article-title><source>Kardiol Pol</source><year>2005</year><volume>63</volume><issue>7</issue><fpage>50</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">16136429</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabik 3rd</surname><given-names>JF</given-names></name><name><surname>Olivares</surname><given-names>G</given-names></name><name><surname>Raza</surname><given-names>S</given-names></name><name><surname>Lytle</surname><given-names>BW</given-names></name><name><surname>Houghtaling</surname><given-names>PL</given-names></name><name><surname>Blackstone</surname><given-names>EH</given-names></name></person-group><article-title>Does grafting coronary arteries with only moderate stenosis
affect long-term mortality</article-title><source>J Thorac Cardiovasc Surg</source><year>2016</year><volume>151</volume><issue>3</issue><fpage>806</fpage><lpage>811</lpage><pub-id pub-id-type="pmid">26611750</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Authors/Task Force members</collab><name><surname>Windecker</surname><given-names>S</given-names></name><name><surname>Kolh</surname><given-names>P</given-names></name><name><surname>Alfonso</surname><given-names>F</given-names></name><name><surname>Collet</surname><given-names>JP</given-names></name><name><surname>Cremer</surname><given-names>J</given-names></name><name><surname>Falk</surname><given-names>V</given-names></name><etal/></person-group><article-title>2014 ESC/EACTS Guidelines on myocardial revascularization: the
Task Force on Myocardial Revascularization of the European Society of
Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery
(EACTS) developed with the special contribution of the European Association
of Percutaneous Cardiovascular Interventions (EAPCI)</article-title><source>Eur Heart J</source><year>2014</year><volume>35</volume><issue>37</issue><fpage>2541</fpage><lpage>2619</lpage><pub-id pub-id-type="pmid">25173339</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname><given-names>NL</given-names></name><name><surname>Ochsner</surname><given-names>JL</given-names></name></person-group><article-title>Technique of internal mammary-to-coronary artery
bypass</article-title><source>Ann Thorac Surg</source><year>1974</year><volume>17</volume><issue>3</issue><fpage>237</fpage><lpage>246</lpage><pub-id pub-id-type="pmid">4591526</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crowley</surname><given-names>JJ</given-names></name><name><surname>Shapiro</surname><given-names>LM</given-names></name></person-group><article-title>Noninvasive assessment of left internal mammary artery graft
patency using transthoracic echocardiography</article-title><source>Circulation</source><year>1995</year><volume>92</volume><issue>9</issue><supplement>Suppl</supplement><fpage>II25</fpage><lpage>II30</lpage><pub-id pub-id-type="pmid">7586418</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madaric</surname><given-names>J</given-names></name><name><surname>Mistrik</surname><given-names>A</given-names></name><name><surname>Riecansky</surname><given-names>I</given-names></name><name><surname>Vulev</surname><given-names>I</given-names></name><name><surname>Pacak</surname><given-names>J</given-names></name><name><surname>Verhamme</surname><given-names>K</given-names></name><etal/></person-group><article-title>Left internal mammary artery bypass dysfunction after
revascularization of moderately narrowed coronary lesions. Colour-duplex
ultrasound versus angiography study</article-title><source>Eur J Echocardiogr</source><year>2008</year><volume>9</volume><issue>2</issue><fpage>273</fpage><lpage>277</lpage><pub-id pub-id-type="pmid">17588499</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Braunwald</surname><given-names>E</given-names></name><name><surname>Mark</surname><given-names>DB</given-names></name><name><surname>Jones</surname><given-names>RH</given-names></name><name><surname>Cheitlin</surname><given-names>MD</given-names></name><name><surname>Fuster</surname><given-names>V</given-names></name><name><surname>McCauley</surname><given-names>KM</given-names></name><etal/></person-group><source>Unstable angina: diagnosis and management. Clinical practice
guideline</source><year>1997</year><publisher-loc>Rockville</publisher-loc><publisher-name>DIANE Publishing</publisher-name></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bech</surname><given-names>GJ</given-names></name><name><surname>De Bruyne</surname><given-names>B</given-names></name><name><surname>Pijls</surname><given-names>NH</given-names></name><name><surname>Muinck</surname><given-names>ED</given-names></name><name><surname>Hoorntje</surname><given-names>JC</given-names></name><name><surname>Escaned</surname><given-names>J</given-names></name><etal/></person-group><article-title>Fractional flow reserve to determine the appropriateness of
angioplasty in moderate coronary stenosis: a randomized
trial</article-title><source>Circulation</source><year>2001</year><volume>103</volume><issue>24</issue><fpage>2928</fpage><lpage>2934</lpage><pub-id pub-id-type="pmid">11413082</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wongpraparut</surname><given-names>N</given-names></name><name><surname>Yalamanchili</surname><given-names>V</given-names></name><name><surname>Pasnoori</surname><given-names>V</given-names></name><name><surname>Satran</surname><given-names>A</given-names></name><name><surname>Chandra</surname><given-names>M</given-names></name><name><surname>Masden</surname><given-names>R</given-names></name><etal/></person-group><article-title>Thirty-month outcome after fractional flow reserve-guided versus
conventional multivessel percutaneous coronary intervention</article-title><source>Am J Cardiol</source><year>2005</year><volume>96</volume><issue>7</issue><fpage>877</fpage><lpage>884</lpage><pub-id pub-id-type="pmid">16188509</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toth</surname><given-names>G</given-names></name><name><surname>De Bruyne</surname><given-names>B</given-names></name><name><surname>Casselman</surname><given-names>F</given-names></name><name><surname>De Vroey</surname><given-names>F</given-names></name><name><surname>Pyxaras</surname><given-names>S</given-names></name><name><surname>Di Serafino</surname><given-names>L</given-names></name></person-group><article-title>Fractional flow reserve-guided versus angiography-guided coronary
artery bypass graft surgery</article-title><source>Circulation</source><year>2013</year><volume>128</volume><issue>13</issue><fpage>1405</fpage><lpage>1411</lpage><pub-id pub-id-type="pmid">23985788</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Botman</surname><given-names>CJ</given-names></name><name><surname>Schonberger</surname><given-names>J</given-names></name><name><surname>Koolen</surname><given-names>S</given-names></name><name><surname>Penn</surname><given-names>O</given-names></name><name><surname>Botman</surname><given-names>H</given-names></name><name><surname>Dib</surname><given-names>N</given-names></name><etal/></person-group><article-title>Does stenosis severity of native vessels influence bypass graft
patency? A prospective fractional flow reserve-guided study</article-title><source>Ann Thorac Surg</source><year>2007</year><volume>83</volume><issue>6</issue><fpage>2093</fpage><lpage>2097</lpage><pub-id pub-id-type="pmid">17532405</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeff</surname><given-names>RH</given-names></name><name><surname>Kongtahworn</surname><given-names>C</given-names></name><name><surname>Iannone</surname><given-names>LA</given-names></name><name><surname>Gordon</surname><given-names>DF</given-names></name><name><surname>Brown</surname><given-names>TM</given-names></name><name><surname>Phillips</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>Internal mammary artery versus saphenous vein graft to the left
anterior descending coronary artery: prospective randomized study with
10-year follow-up</article-title><source>Ann Thorac Surg</source><year>1988</year><volume>45</volume><issue>5</issue><fpage>533</fpage><lpage>536</lpage><pub-id pub-id-type="pmid">3259128</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manabe</surname><given-names>S</given-names></name><name><surname>Fukui</surname><given-names>T</given-names></name><name><surname>Tabata</surname><given-names>M</given-names></name><name><surname>Shimokawa</surname><given-names>T</given-names></name><name><surname>Morita</surname><given-names>S</given-names></name><name><surname>Takanashi</surname><given-names>S</given-names></name></person-group><article-title>Arterial graft deterioration one year after coronary artery
bypass grafting</article-title><source>J Thorac Cardiovasc Surg</source><year>2010</year><volume>140</volume><issue>6</issue><fpage>1306</fpage><lpage>1311</lpage><pub-id pub-id-type="pmid">20346466</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villareal</surname><given-names>RP</given-names></name><name><surname>Mathur</surname><given-names>VS</given-names></name></person-group><article-title>The string phenomenon: an important cause of internal mammary
artery graft failure</article-title><source>Tex Heart Inst J</source><year>2000</year><volume>27</volume><issue>4</issue><fpage>346</fpage><lpage>349</lpage><pub-id pub-id-type="pmid">11198306</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dimitrova</surname><given-names>KR</given-names></name><name><surname>Hoffman</surname><given-names>DM</given-names></name><name><surname>Geller</surname><given-names>CM</given-names></name><name><surname>Dincheva</surname><given-names>G</given-names></name><name><surname>Ko</surname><given-names>W</given-names></name><name><surname>Tranbaugh</surname><given-names>RF</given-names></name></person-group><article-title>Arterial grafts protect the native coronary vessels from
atherosclerotic disease progression</article-title><source>Ann Thorac Surg</source><year>2012</year><volume>94</volume><issue>2</issue><fpage>475</fpage><lpage>481</lpage><pub-id pub-id-type="pmid">22727250</pub-id></element-citation></ref></ref-list></back></article>